HOME > TOP STORIES
TOP STORIES
-
ACADEMIA MHLW Study Group Aims to Formulate Guidelines for Treatment of Skeletal Dysplasias in FY2017
June 29, 2016
-
ACADEMIA Nexium, Takecab Added to Standard Treatments for 1st Eradication of H. Pylori: JSHR Guidelines
June 28, 2016
-
REGULATORY MHLW Vows to Forge Ties with UK Counterpart in Post-Brexit Regulations
June 27, 2016
-
REGULATORY Registration System for Prevention of Dementia to Begin Operation; Will Provide Info on Clinical Research, Trials
June 24, 2016
-
BUSINESS Sanofi’s Antibody Drug for Atopic Dermatitis Close to Regulatory Filing
June 23, 2016
-
BUSINESS Interview: Bayer Yakuhin Chief Spearheading Initiatives to Trigger Behavior Change in Employees
June 23, 2016
-
BUSINESS Bayer Japan Revs Up Drive to Spark Behavior Change, Offers Patient Insights to Back Office Staffers
June 22, 2016
-
REGULATORY Exemption from Bioequivalence Studies Adopted as New Topic at ICH Meeting in Lisbon; Could Affect Generics as Well
June 22, 2016
-
TRENDS Top Global Pharmas Lackluster in Japan while Hep C Drug Makers Flourish
June 21, 2016
-
BUSINESS Aspen Japan Looks to Expand Biz through Essential Drugs, AGs: President
June 20, 2016
-
ACADEMIA No Increased Mortality Risks Seen in Japanese AD Patients on Antipsychotics: Study
June 17, 2016
-
BUSINESS Merck Serono Can Catch Up with Rivals in Immuno-Oncology Space: Japan Oncology Head
June 16, 2016
-
REGULATORY Greater than Expected Need for Drug Discovery Research Using Existing Drugs: AMED Project
June 16, 2016
-
ACADEMIA Victoza 1st GLP-1 Agent to Thwart Cardiovascular Events; Will It Catch on?
June 15, 2016
-
ACADEMIA As Spate of Melanoma Drugs Debut, Physicians Still Exploring Best Drug Choices, Combos
June 14, 2016
-
ORGANIZATION FPMAJ Drug Pricing Affairs Chief Lashes Out at Proposed Out-of-Cycle Re-Pricing
June 13, 2016
-
BUSINESS Takeda Looks to Join Top 10 List in Global Oncology Space in 2025
June 10, 2016
-
REGULATORY Upcoming ICH Meeting Expected to Approve New Members Including Generic Drug Organization
June 9, 2016
-
BUSINESS FY2015 Earnings Roundup - 3: Japan Market Stagnates despite No Drug Price Revision, Off-Patent Brands Weigh
June 8, 2016
-
BUSINESS FY2015 Earnings Roundup - 2: New Drugs Gain Traction Overseas to Underpin Japan Makers’ Financial Results
June 7, 2016
ページ
I recently sat down with one of the leading medical directors in Japan to discuss the critical evolution of the medical science liaison (MSL) role.The MSL has transformed from a scientific resource into a strategic partner essential for successful product…
